Elizabeth A. Mittendorf
Experienced in Menopause

Dr. Elizabeth A. Mittendorf

Surgical Oncology
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center - Surgery
330 Brookline Avenue, Shapiro 5, 
Boston, MA 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Menopause
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center - Surgery
330 Brookline Avenue, Shapiro 5, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Mittendorf is a Surgical Oncologist in Boston, Massachusetts. Dr. Mittendorf is rated as an Experienced provider by MediFind in the treatment of Menopause. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Lymphadenectomy.

Her clinical research consists of co-authoring 354 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Menopause.

Graduate Institution
Case Western Reserve University School Of Medicine
Residency
Case Western Reserve University Hospitals
Specialties
Surgical Oncology
Licenses
Surgery in TX
Board Certifications
American Board Of Surgery
Fellowships
The University of Texas MD Anderson Cancer Center
Hospital Affiliations
Brigham And Women's Hospital
Brigham And Women's Faulkner Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Beth Israel Deaconess Medical Center - Surgery
330 Brookline Avenue, Shapiro 5, Boston, MA 02215
Call: 617-667-2900

Additional Areas of Focus

Dr. Mittendorf has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Mastectomy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Device, Other
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Procedure
Study Phase: Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
A Pilot Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab [MEDI4736]) Plus Anti-CTLA-4 Antibody (Tremelimumab) in Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer
A Pilot Pre-Surgical Study Evaluating Anti-PD-L1 Antibody (Durvalumab [MEDI4736]) Plus Anti-CTLA-4 Antibody (Tremelimumab) in Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer
Enrollment Status: Completed
Publish Date: June 05, 2024
Intervention Type: Biological
Study Drugs: Durvalumab, Tremelimumab
Study Phase: Early Phase 1
Phase II Trial of Combination Immunotherapy With Nelipepimut-S + GM-CSF (NeuVax™) and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Phase II Trial of Combination Immunotherapy With Nelipepimut-S + GM-CSF (NeuVax™) and Trastuzumab in High-risk HER2+ Breast Cancer Patients
Enrollment Status: Completed
Publish Date: December 12, 2023
Intervention Type: Biological, Drug
Study Drugs: NeuVax vaccine, Trastuzumab, GM-CSF
Study Phase: Phase 2
VADIS Trial: Phase II Trial of Nelipeimut-S Peptide Vaccine in Women With DCIS of the Breast
VADIS Trial: Phase II Trial of Nelipeimut-S Peptide Vaccine in Women With DCIS of the Breast
Enrollment Status: Completed
Publish Date: December 05, 2023
Intervention Type: Drug, Other, Biological, Procedure
Study Drugs: Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim
Study Phase: Phase 2
A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization
A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization
Enrollment Status: Completed
Publish Date: February 04, 2021
Intervention Type: Device
Study Phase: Not Applicable
Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence
Combination Immunotherapy With Herceptin and the HER2 Vaccine E75 in Low and Intermediate HER2-expressing Breast Cancer Patients to Prevent Recurrence
Enrollment Status: Completed
Publish Date: December 02, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

354 Total Publications

Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial.
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial.
Journal: Future oncology (London, England)
Published: October 08, 2025
View All 354 Publications
Similar Doctors
Olga Kantor
Experienced in Menopause
Dr. Olga Kantor
General Surgery | Surgical Oncology
Experienced in Menopause
Dr. Olga Kantor
General Surgery | Surgical Oncology

Dana-Farber Cancer Institute, Inc.

450 Brookline Ave, 
Boston, MA 
 (0.1 miles away)
617-632-3586
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Olga Kantor is a General Surgeon and a Surgical Oncologist in Boston, Massachusetts. Dr. Kantor is rated as a Distinguished provider by MediFind in the treatment of Menopause. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Pancreaticoduodenectomy. Dr. Kantor is currently accepting new patients.

VIEW MORE MENOPAUSE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mittendorf's expertise for a condition
ConditionClose
  • Elite
  • Breast Cancer
    Dr. Mittendorf is
    Elite
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • HER-2 Positive Breast Cancer
    Dr. Mittendorf is
    Elite
    . Learn about HER-2 Positive Breast Cancer.
    See more HER-2 Positive Breast Cancer experts
  • Triple-Negative Breast Cancer
    Dr. Mittendorf is
    Elite
    . Learn about Triple-Negative Breast Cancer.
    See more Triple-Negative Breast Cancer experts
  • Distinguished
  • Inflammatory Breast Cancer
    Dr. Mittendorf is
    Distinguished
    . Learn about Inflammatory Breast Cancer.
    See more Inflammatory Breast Cancer experts
  • Advanced
  • Angiosarcoma
    Dr. Mittendorf is
    Advanced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Intraductal Papilloma
    Dr. Mittendorf is
    Advanced
    . Learn about Intraductal Papilloma.
    See more Intraductal Papilloma experts
  • Paget Disease of the Breast
    Dr. Mittendorf is
    Advanced
    . Learn about Paget Disease of the Breast.
    See more Paget Disease of the Breast experts
  • Experienced
  • Bone Tumor
    Dr. Mittendorf is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Lymphadenectomy
    Dr. Mittendorf is
    Experienced
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Melanoma
    Dr. Mittendorf is
    Experienced
    . Learn about Melanoma.
    See more Melanoma experts
  • Menopause
    Dr. Mittendorf is
    Experienced
    . Learn about Menopause.
    See more Menopause experts
  • Neuroendocrine Tumor
    Dr. Mittendorf is
    Experienced
    . Learn about Neuroendocrine Tumor.
    See more Neuroendocrine Tumor experts
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.